Jennifer Koenitzer, PhD
About Jennifer Koenitzer, PhD
Jennifer Koenitzer, PhD, is the Scientific Director of Immunology, CV, Fibrosis & Neuroscience Disease Team, Translational Medicine at Bristol Myers Squibb in Princeton, New Jersey.
Company
Jennifer Koenitzer, PhD, currently works at Bristol Myers Squibb (BMS) in Princeton, New Jersey, United States. BMS is a global biopharmaceutical company committed to discovering, developing, and delivering innovative medicines for patients with serious diseases. Jennifer has held multiple roles within the company, starting from a Research Investigator II in Immuno-Oncology R&D Antibody Discovery to her present position as Scientific Director in the Translational Medicine department.
Title and Role
Jennifer Koenitzer serves as the Scientific Director of Immunology, Cardiovascular, Fibrosis, and Neuroscience Disease Team within Translational Medicine at Bristol Myers Squibb. In this capacity, she leads a team that executes wet lab experiments for Phase 2+ assets. She is responsible for developing and implementing research strategies to investigate mechanisms of action, competitor benchmarking, and biomarker profiling studies across multiple therapeutic areas.
Education and Expertise
Jennifer holds an impressive academic background with a PhD in Immunology and Molecular Pathology from University College London (2006-2010), an MBA from London Business School (2007-2009), a Master's degree in Molecular Biotechnology from Friedrich-Schiller-Universität Jena (2004-2006), and a Bachelor's degree in Biochemistry and Molecular Biology from the same institution (2001-2004). Her expertise includes high throughput assay design, multiplexed biomarker profiling, single-cell functional proteomics, antibody engineering, genomics, transcriptomics, and systems biology.
Professional Background
Jennifer’s professional journey includes significant roles at multiple organizations. Prior to her current role at Bristol Myers Squibb, she worked there as Senior Principal Scientist and Senior Research Investigator in Immuno-Oncology. She also held roles at Boehringer Ingelheim in Germany, including Principal Scientist in immune modulation and biologics discovery and Senior Scientist in biopharmaceuticals. Her early career involved research positions at prestigious institutions like University College London and institutions in Germany such as Friedrich-Schiller-Universität Jena.
Achievements and Skills
Jennifer has led the development of new laboratory teams and mentored scientists at various levels. She has a proven track record in implementing research strategies and is skilled in various advanced techniques such as Luminex, MSD, ELISA, and antibody engineering, including CD3 bi-specifics. Additionally, she has extensive experience in protein expression and purification. Her passion for data visualization and proficiency in tools like R and Tableau further showcase her comprehensive skill set.